Underutilization of glucose data and lack of easy and standardized glucose data collection, analysis, visualization, and guided clinical decision making are key contributors to poor glycemic control among individuals with type 1 diabetes mellitus. An expert panel of diabetes specialists, facilitated by the International Diabetes Center and sponsored by the Helmsley Charitable Trust, met in 2012 to discuss recommendations for standardizing the analysis and presentation of glucose monitoring data, with the initial focus on data derived from continuous glucose monitoring systems. The panel members were introduced to a universal software report, the Ambulatory Glucose Profile, and asked to provide feedback on its content and functionality, both as a research tool and in clinical settings. This article provides a summary of the topics and issues discussed during the meeting and presents recommendations from the expert panel regarding the need to standardize glucose Profile summary metrics and the value of a uniform glucose report to aid clinicians, researchers, and patients.
MazzeRSStrockEWesleyDBorgmanSMorganBBergenstalRCuddihyR.Characterizing glucose exposure for individuals with normal glucose tolerance using continuous glucose monitoring and ambulatory glucose Profile analysis. Diabetes Technol Ther.2008;10 (3): 149–59.
MillerKMBeckRWBergenstalRMGolandRSHallerMJMcGillJBRodriguezHSimmonsJH, Hirsch IB; for the T1D Exchange Clinic Network. Evidence of a strong association between frequency of self-monitoring of blood glucose and hemoglobin A1C levels in T1D Exchange clinic registry participants. Diabetes Care.2013. Epub ahead of print.
5.
Di BattistaAMHartTAGrecoLGloizerJ.Type 1 diabetes among adolescents: Reduced diabetes self-care caused by social fear and fear of hypoglycemia. Diabetes Educ.2009;35 (3): 465–75.
6.
MorrisADBoyleDIMcMahonADGreeneSAMacDonaldTMNewtonRW, Adherence to insulin treatment, glycaemic control, and ketoacidosis in insulin-dependent diabetes mellitus. The DARTS/MEMO Collaboration. Diabetes Audit and Research in Tayside Scotland. Medicines Monitoring Unit. Lancet.1997;350 (9090): 1505–10.
7.
SmithCBChoudharyPPernetAHopkinsDAmielSA, Hypoglycemia unawareness is associated with reduced adherence to therapeutic decisions in patients with type 1 diabetes: Evidence from a clinical audit. Diabetes Care.2009;32 (7): 1196–8.
8.
McGill1JBChenVBeckRW, Diabetes management among adults under excellent control in the type 1 diabetes exchange clinic registry: How do they do it?EASD2012 Berlin, oral presentation, 186.
9.
WildDvon MaltzahnRBrohanEChristensenTClausonPGonder-FrederickL.A critical review of the literature on fear of hypoglycemia in diabetes: Implications for diabetes management and patient education. Patient Educ Couns.2007;68 (1): 10–5.
10.
BrouhardBH, Hypoglycemia. In: TravisLBBrouhardBHSchreinerBJ, eds. Diabetes mellitus in children and adolescents. Philadelphia: W.B. Saunders; 1987, 169–78.
11.
CryerPE, Hypoglycaemia: The limiting factor in the glycaemic management of type I and type II diabetes. Diabetologia.2002;45 (7): 937–48.
12.
AnderbroTAmsbergSAdamsonUBolinderJLinsPEWredlingRMobergELisspersJJohanssonUB, Fear of hypoglycaemia in adults with type 1 diabetes. Diabet Med.2010;27 (10): 1151–8.
13.
SacksDB, Hemoglobin a1c in diabetes: Panacea or pointless?Diabetes.2013;62 (1): 41–3.
14.
HirschIBAmielSABlumerIRBodeBWEdelmanSVSeleyJJVerdereseCAKilepatrickES, Using multiple measures of glycemia to support individualized diabetes management: Recommendations for clinicians, patients, and payers. Diabetes Technol Ther.2012;14 (11): 973–83.
15.
ZoungasSPatelAChalmersJde GalanBELiQBillotLWoodwardMNinomiyaTNealBMacMahonSGrobbeeDEKengneAPMarreMHellerS; ADVANCE Collaborative Group. Severe hypoglycemia and risks of vascular events and death. N Engl J Med.2010;363 (15): 1410–8.
16.
SeaquistERMillerMEBondsDEFeinglosMGoffDCJrPetersonKSeniorP; ACCORD Investigators. The impact of frequent and unrecognized hypoglycemia on mortality in the ACCORD study. Diabetes Care.2012;35 (2): 409–14.
17.
McCoyRGVan HoutenHKZiegenfussJYShahNDWermersRASmithSA, Increased mortality of patients with diabetes reporting severe hypoglycemia. Diabetes Care.2012;35 (9): 1897–901.
18.
CryerPE, Severe hypoglycemia predicts mortality in diabetes. Diabetes Care.2012;35 (9): 1814–6.
19.
MonnierLMasEGinetCMichelFVillonLCristolJPColetteC.Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA.2006;295 (14): 1681–7.
20.
EspositoKCiotolaMCarleoDSchisanoBSardelliLDi TommasoDMissoLSaccomannoFCerielloAGiuglianoD.Post-meal glucose peaks at home associate with carotid intima-media thickness in type 2 diabetes. J Clin Endocrinol Metab.2008;93 (4): 1345–50.
21.
MonnierLColetteCLeiterLCerielloAHanefeldMOwensDTajimaNTuomilethoJDavidsonJ; PGR Group. The effect of glucose variability on the risk of microvascular complications in type 1 diabetes. Diabetes Care.2007;30 (1): 185–8.
22.
SiegelaarSEHollemanFHoekstraJBDeVriesJH, Glucose variability; does it matter?Endocr Rev.2010;31 (2): 171–82.
23.
MonnierLWojtusciszynAColetteCOwensD.The contribution of glucose variability to asymptomatic hypoglycemia in persons with type 2 diabetes. Diabetes Technol Ther.2011;13 (8): 813–8.
24.
QuYJacoberSJZhangQWolkaLLDeVriesJH, Rate of hypoglycemia in insulin- treated patients with type 2 diabetes can be predicted from glycemic variability data. Diabetes Technol Ther.2012;14 (11): 1008–12.
25.
RodbardDBaileyTJovanovicLZisserHKaplanRGargSK, Improved quality of glycemic control and reduced glycemic variability with use of continuous glucose monitoring. Diabetes Technol Ther.2009;11 (11): 717–23.
26.
TestaMAGillJSuMTurnerRRBlondeLSimonsonDC, Comparative effectiveness of basal-bolus versus premix analog insulin on glycemic variability and patient-centered outcomes during insulin intensification in type 1 and type 2 diabetes: A randomized, controlled, crossover trial. J Clin Endocrinol Metab.2012;97 (10): 3504–14.
27.
BerwickDMNolanTWWhittingtonJ.The triple aim: Care, health, and cost. Health Aff (Millwood).2008;27 (3): 759–69.
28.
Centers for Disease Control and Prevention (CDC). Self-monitoring of blood glucose among adults with diabetes-United States, 1997–2006. MMWR Morb Mortal Wkly Rep.2007;56 (43): 1133–7.
29.
MuchmoreD.The end point is just the beginning. J Diabetes Sci Technol.2011;5 (5): 1287–9.
30.
Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group, BodeBBeckRWXingDGilliamLHirschIKollmanCLaffelLRuedyKJTamborlaneWVWeinzimerSWolpertH.Sustained benefit of continuous glucose monitoring on A1C, glucose Profiles, and hypoglycemia in adults with type 1 diabetes. Diabetes Care.2009;32 (11): 2047–9.
ZinmanBSchmidtWEMosesALundNGoughS.Achieving a clinically relevant composite outcome of an HbA1c of <7% without weight gain or hypoglycaemia in type 2 diabetes: A meta-analysis of the liraglutide clinical trial programme. Diabetes Obes Metab.2012;14 (1): 77–82.
33.
BergenstalRMLiYPorterTKWeaverCHanJ.Exenatide once weekly improved glycaemic control, cardiometabolic risk factors and a composite index of an HbA1c <7%, without weight gain or hypoglycaemia, over 52 weeks. Diabetes Obes Metab.2013;15 (3): 264–71.
34.
CheungBMOngKLChernySSShamPCTsoAWLamKS, Diabetes prevalence and therapeutic target achievement in the United States, 1999 to 2006. Am J Med.2009;122 (5): 443–53.
35.
The D5. The five goals for living well with diabetes. http://www.thed5.org. Accessed November 5, 2012.
GaedePLund-AndersenHParvingHHPedersenO.Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med.2008;358 (6): 580–91.
38.
BodeBWBeckRWDuBoseSNBodeBWPetersALHirschIBMillerKM; T1D Exchange Clinic Network. A comparison of users and nonusers of real-time continuous glucose monitoring with type 1 diabetes in the type 1 diabetes exchange. J Diabetes Sci Technol.2012;6 (2): A18.
39.
RyanEAGermsheidJ.Use of continuous glucose monitoring system in the management of severe hypoglycemia. Diabetes Technol Ther.2009;11 (10): 635–9.
40.
GeigerMCFerreiraJVHafizMMFroudTBaidalDAMeneghiniLFRicordiCAlejandroR.Evaluation of metabolic control using a continuous subcutaneous glucose monitoring system in patients with type 1 diabetes mellitus who achieved insulin independence after islet cell transplantation. Cell Transplant.2005;14 (2–3): 77–84.
41.
BaileyTSZisserHCGargSK, Reduction in hemoglobin A1C with real-time continuous glucose monitoring: Results from a 12-week observational study. Diabetes Technol Ther.2007;9 (3): 203–10.
42.
GargSJovanovicL.Relationship of fasting and hourly blood glucose levels to HbA1c values: Safety, accuracy, and improvements in glucose Profiles obtained using a 7-day continuous glucose sensor. Diabetes Care.2006;29 (12): 2644–9.
43.
GargSZisserHSchwartzSBaileyTKaplanREllisSJovanovicL.Improvement in glycemic excursions with a transcutaneous, real-time continuous glucose sensor: A randomized controlled trial. Diabetes Care.2006;29 (1): 44–50.
44.
BattelinoTCongetIOlsenBSchütz-FuhrmannIHommelEHoogmaRSchierlohUSulliNBolinderJ; SWITCH Study Group. The use and efficacy of continuous glucose monitoring in type 1 diabetes treated with insulin pump therapy: A randomised controlled trial. Diabetologia.2012;55 (12): 3155–62.
45.
PickupJCFreemanSCSuttonAJ, Glycaemic control in type 1 diabetes during real time continuous glucose monitoring compared with self-monitoring of blood glucose: Meta-analysis of randomised controlled trials using individual patient data. BMJ.2011;343: d3805.
46.
YehHCBrownTTMaruthurNRanasinghePBergerZSuhYDWilsonLMHaberlEBBrickJBassEBGoldenSH, Comparative effectiveness and safety of methods of insulin delivery and glucose monitoring for diabetes mellitus: A systematic review and meta-analysis. Ann Intern Med.2012;157 (5): 336–47.
47.
Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group, BeckRWHirschIBLaffelLTamborlaneWVBodeBWBuckinghamBChasePClemonsRFiallo-ScharerRFoxLAGilliamLKHuangESKollmanCKowalskiAJLawrenceJMLeeJMaurasNO'GradyMRuedyKJTanseyMTsalikianEWeinzimerSAWilsonDMWolpertHWysockiTXingD. The effect of continuous glucose monitoring in well-controlled type 1 diabetes. Diabetes Care.2009;32 (8): 1378–83.
48.
VigerskyRAFondaSJChellappaMWalkerMSEhrhardtNM, Short- and long-term effects of real-time continuous glucose monitoring in patients with type 2 diabetes. Diabetes Care.2012;35 (1): 32–8.
49.
BattelinoTPhillipMBratinaNNimriROskarssonPBolinderJ.Effect of continuous glucose monitoring on hypoglycemia in type 1 diabetes. Diabetes Care.2011;34 (4): 795–800.
50.
DeissDBolinderJRivelineJPBattelinoTBosiETubiana-RufiNKerrDPhillipM.Improved glycemic control in poorly controlled patients with type 1 diabetes using real-time continuous glucose monitoring. Diabetes Care.2006;29 (12): 2730–2.
51.
HirschIBAbelsethJBodeBWFischerJSKaufmanFRMastrototaroJParkinCGWolpertHABuckinghamBA, Sensor-augmented insulin pump therapy: Results of the first randomized treat-to-target study. Diabetes Technol Ther.2008;10 (5): 377–83.
52.
BrewerKWChaseH POwenSGargSK, Slicing the pie. Correlating HbA–values with average blood glucose values in a pie chart form. Diabetes Care.1998;21 (2): 209–12.
53.
KowalskiAJ, Can we really close the loop and how soon? Accelerating the availability of an artificial pancreas: A roadmap to better diabetes outcomes. Diabetes Technol Ther.2009;11Suppl 1: S113–9.
54.
NathanDMKuenenJBorgRZhengHSchoenfeldDHeineRJ; A1c-Derived Average Glucose Study Group. Translating the A1C assay into estimated average glucose values. Diabetes Care.2008;31 (8): 1473–8.
55.
RodbardD.Interpretation of continuous glucose monitoring data: Glycemic variability and quality of glycemic control. Diabetes Technol Ther.2009;11Suppl 1: S55–67.
56.
KovatchevBPCoxDJGonder-FrederickLAYoung-HymanDSchlundtDClarkeW.Assessment of risk for severe hypoglycemia among adults with IDDM: Validation of the low blood glucose index. Diabetes Care.1998;21 (11): 1870–5.
57.
KovatchevBPOttoECoxDGonder-FrederickLClarkeW.Evaluation of a new measure of blood glucose variability in diabetes. Diabetes Care.2006;29 (11): 2433–8.
58.
RodbardD.Hypo- and hyperglycemia in relation to the mean, standard deviation, coefficient of variation, and nature of the glucose distribution. Diabetes Technol Ther.2012;14 (10): 868–76.
59.
Workgroup on Hypoglycemia, American Diabetes Association. Defining and reporting hypoglycemia in diabetes: A report from the American Diabetes Association Workgroup on Hypoglycemia. Diabetes Care.2005;28 (5): 1245–9.
60.
American Diabetes Association. Standards of Medical Care in Diabetes–2013. Diabetes Care.2013;36Suppl 1: S11–66.
61.
DunnTCCroutherN.Assessment of the variance of the ambulatory glucose Profile over 3–20 days of continuous glucose monitoring. EASD, Stockholm, Abstract. September 2010.
62.
MazzeRStrockEMorganBWesleyDBergenstalRCuddihyR.Diurnal glucose patterns of exenatide once weekly: A 1-year study using continuous glucose monitoring with ambulatory glucose Profile analysis. Endocr Pract.2009;15 (4): 326–34.
